Benzinga's Volume Movers (THRX, TPCG, PRGS, ALXN)

Theravance Inc THRX shares moved up 4.77% to $18.00 at 12:29 pm. The volume of THRX shares traded was 373% higher than normal. Theravance and GlaxoSmithKline Plc GSK announced that their lung disease and asthma drug, Relovair has passed in a mid-stage safety study. TPC Group Inc TPCG shares rose 3.17% to $22.10. The volume of TPCG shares traded was 366% higher than normal. TPCG had started an offering of $325 million worth senior secured notes due 2017. Progress Software Corp PRGS shares climbed 6.54% to $31.92. The volume of PRGS shares traded was 261% higher than normal. PRGS had reported better-than-expected results for its FQ3. Alexion Pharmaceuticals Inc ALXN shares gained 4.04% to $63.67. The volume of ALXN shares traded was 234% higher than normal. ALXN earnings are likely to gain 736.26% in this year. Read more from Benzinga's Company news.